| 4-chloro-3-[[(2S,3R)-2-(4-chlorophenyl)-4,4,4-trifluoro-3-methyl-1-oxobutyl]amino]-cyclopropyl-(S)-Benzenepropanoic acid |
RUNCACIGUAT |
1402936-61-1 |
| Cdc7-IN-1 |
CDC7-IN-1 (COMPOUND 13) |
1402055-25-7 |
| IDO-IN-8 |
1402837-77-7 |
1402837-77-7 |
| IDO-IN-6 |
1402837-76-6 |
1402837-76-6 |
| 2-Chloro-N,N-diethyl-5-[[4-[2-[4-[[(MethylaMino)carbonyl]aMino]phenyl]-4-pyridinyl]-2-pyriMidinyl]aMino]benzenesulfonaMide |
嘧啶杂质1 |
1402452-15-6 |
| Pyrotinib Maleate |
马来酸吡咯替尼 |
1397922-61-0 |
| Conteltinib
(CT-707) |
CONTELTINIB (CT-707) |
1384860-29-0 |
| EPZ004777 HCl |
1380316-03-9 |
1380316-03-9 |
| ARN 077
(ARN077) |
化合物 T10370 |
1373625-34-3 |
| tert-butyl 2-((4R,6R)-6-(2-((3R,5R)-7-(2-(4-fluorophenyl)-5- isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5- dihydroxyheptanamido)ethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate |
阿托伐他汀钙杂质22 |
1371615-55-2 |
| 3-chloro-4-(6-hydroxyquinolin-2-yl)benzoic acid |
CAVOSONSTAT (N91115) |
1371587-51-7 |
| OG-L002 hydrochloride |
OGL002; OG L002 |
1357298-75-9 |
| (R)-2-((3-aminopiperidin-1-yl)methyl)benzonitrile |
阿格列汀杂质28 |
1353254-17-7 |
| EIPA hydrochloride |
EIPA HYDROCHLORIDE |
1345839-28-2 |
| 4-((2S,5S)-13-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5-isopropyl-4,7-dioxo-2-(3-ureidopropyl)-8,11-dioxa-3,6-diazatridecanamido)benzyl (2-(((((S)-1-(chloromethyl)-3-(6-(4-hydroxybenzamido)imidazo[1,2-a]pyridine-2-carbonyl)-9-methyl-2,3-dihydro-1H-benzo[e]indol-5-yl)oxy)carbonyl)(2-(2-hydroxyethoxy)ethyl)amino)ethyl)(methyl)carbamate |
VC-SECO-DUBA |
1345681-58-4 |
| CFI-400945 |
CFI-400945 |
1338800-06-8 |
| MPT0E028 |
MPT0E028 |
1338320-94-7 |
| GSK682753A |
1334294-76-6 |
1334294-76-6 |
| Nordoxepin-d3 HCl |
Nordoxepin-d3 HCl |
1331665-54-3 |
| Phenylbutazone-13C12 |
苯基布洛芬-13C12 |
1325559-13-4 |
QQ
微信
